{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:15:09Z","timestamp":1790806509454,"version":"4.1.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 77-year-old woman with history of breast cancer presented with 2 unclear dural contrast-enhancing lesions on MRI; differential diagnoses were breast cancer metastases and meningiomas. On <jats:sup>68<\/jats:sup>Ga-DOTATOC PET\/CT, the temporal lesion showed high uptake and was classified as meningioma, whereas the lesion at the falx showed barely any <jats:sup>68<\/jats:sup>Ga-DOTATOC uptake uncharacteristic for meningioma and suggestive for a brain metastasis. After resection, histological specimens from the temporal lesion showed meningioma tissue with distinct SSTR2A expression, whereas the falx lesion revealed a breast cancer metastasis without significant SSTR2A expression. Therefore, <jats:sup>68<\/jats:sup>Ga-DOTATOC PET represents a powerful imaging modality for the evaluation of unclear dural lesions.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002513","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T17:43:20Z","timestamp":1552931000000},"page":"412-413","source":"Crossref","is-referenced-by-count":23,"title":["68Ga-DOTATOC PET\/CT Differentiates Meningioma From Dural Metastases"],"prefix":"10.1097","volume":"44","author":[{"given":"Marcus","family":"Unterrainer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Ruf","sequence":"additional","affiliation":[{"name":"Neuropathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harun","family":"Ilhan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital, LMU Munich;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska Jill","family":"Vettermann","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital, LMU Munich;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens C.","family":"Cyran","sequence":"additional","affiliation":[{"name":"Radiology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Niyazi","sequence":"additional","affiliation":[{"name":"Radiation Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bartenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg-Christian","family":"Tonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie Lisa","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/neuonc\/nox112","article-title":"PET imaging in patients with meningioma\u2014report of the RANO\/PET Group","volume":"19","year":"2017","journal-title":"Neuro Oncol"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.2967\/jnumed.117.191932","article-title":"Improved detection of transosseous meningiomas using 68Ga-DOTATATE PET\/CT compared with contrast-enhanced MRI","volume":"58","year":"2017","journal-title":"J Nucl Med"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2967\/jnumed.114.149120","article-title":"Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue","volume":"56","year":"2015","journal-title":"J Nucl Med"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/neuonc\/now001","article-title":"68Gallium-DOTATATE PET in meningioma: a reliable predictor of tumor growth rate?","volume":"18","year":"2016","journal-title":"Neuro Oncol"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1748-717X-4-56","article-title":"[68Ga]-DOTATOC-PET\/CT for meningioma IMRT treatment planning","volume":"4","year":"2009","journal-title":"Radiat Oncol"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1748-717X-7-99","article-title":"Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma","volume":"7","year":"2012","journal-title":"Radiat Oncol"},{"key":"bib7-20230925","first-page":"1538","article-title":"Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE\/-TOC uptake","volume":"18","year":"2016","journal-title":"Neuro Oncol"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13014-018-1056-4","article-title":"Recurrence pattern analysis after [68Ga]-DOTATATE-PET\/CT-planned radiotherapy of high-grade meningiomas","volume":"13","year":"2018","journal-title":"Radiat Oncol"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/RLU.0000000000001793","article-title":"Epidural metastases from follicular thyroid cancer mimicking meningiomas in 68Ga-DOTATATE PET","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/RLU.0000000000001985","article-title":"68Ga-DOTATATE PET\/CT reveals Epstein-Barr virus-associated nasopharyngeal carcinoma in a case of suspected sphenoid wing meningioma","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2002-0007","article-title":"Peptide receptors as molecular targets for cancer diagnosis and therapy","volume":"24","year":"2003","journal-title":"Endocr Rev"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201905000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:01:51Z","timestamp":1695621711000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201905000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002513","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}